Toxoplasmose bij allogene stamcel transplantatie (HSCT)
Advices
Priority | Medication | Remarks |
---|---|---|
Priority: 1st choice |
Medication: cotrimoxazol (trimethoprim +sulfamethoxazol) po 480mg 1dd |
Remarks:
= gelijk aan PJP profylaxe |
Priority: 1st choice alternative |
Medication: cotrimoxazol (trimethoprim +sulfamethoxazol) po |
Remarks:
960 mg 3x per week |
Priority: 2nd choice |
Medication: atovaquon po 1500mg 1dd |
Remarks:
Deze profylaxe is inferieur aan cotrimoxazol. Alleen gebruiken als cotrimoxazol niet mogelijk is |
Sources
-
Pubmed.gov publication # 29855213
Dard C, Marty P, Brenier-Pinchart MP, Garnaud C, Fricker-Hidalgo H, Pelloux H, Pomares C. (2018) Management of toxoplasmosis in transplant recipients: an update. Expert Rev Anti Infect Ther. 16:447-460.
-
Pubmed.gov publication # 26098500
Gajurel K, Dhakal R, Montoya JG. (2015) Toxoplasma prphylaxis in haematopoietic cell transplant recipients: a review of the literature and recommendations. Curr Opin Infect Dis. 28:283-92.
Antimicrobial resources
The following antimicrobial agents have been used in these recommendations:
External antimicrobial resources
Menu position
Metadata
Swab vid: G-500434.2
Updated: 08/23/2021 - 13:26
Status: Published
General comments